CTSS and cancer: Interleukin-6 is implicated in the pathogenesis of cancer-associated weight loss, driving lipid catabolism and muscle protein catabolism [45], [46], perhaps through both lysosomal (cathepsin) and non-lysosomal (proteasome) pathways [47].